Inactive Instrument

Insiders Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Equities

IL0006290147

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing	Mar. 05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing	Mar. 05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing	Mar. 01	MT
Teva Pharmaceutical Industries Ltd. Appoints R. Ananthanarayanan as CEO of Its Teva Active Pharmaceutical Ingredients Business	Nov. 07	CI
Teva Announces Changes to Executive Management Team	23-09-28	CI
Insider Sell: Teva Pharmaceutical Industries	23-08-09	MT
Insider Sell: Teva Pharmaceutical Industries	23-08-03	MT
Teva Pharmaceutical Industries Limited Appoints Varda Shalev as Member of the Board, Effective September 1, 2023	23-08-02	CI
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised	23-08-02	MT
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development, Effective August 1, 2023	23-07-27	CI
Jean-Michel Halfon to Resign from Board of Directors of Teva Pharmaceutical Industries Limited	23-05-11	CI
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-02	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-02	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am EST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm EDT